Clinical trial
A Multi-center, Randomized, Open-label, Non Inferiority Trial to Evaluate the Efficacy and Safety of a Single, Oral Dose of Zoliflodacin Compared to a Combination of a Single Intramuscular Dose of Ceftriaxone and a Single Oral Dose of Azithromycin in the Treatment of Patients With Uncomplicated Gonorrhoea
NCT03959527 is registered in ClinicalTrials.gov with Global Antibiotics Research and Development Partnership as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Randomized, Open-label, Non Inferiority Trial to Evaluate the Efficacy and Safety of a Single, Oral Dose of Zoliflodacin Compared to a Combination of a Single Intramuscular Dose of Ceftriaxone and a Single Oral Dose of Azithromycin in the Treatment of Patients With Uncomplicated Gonorrhoea
- Lead sponsor
- Global Antibiotics Research and Development Partnership
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 6, 2019
- Completion date
- September 18, 2023
- Enrollment
- 1,011 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.